BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7722308)

  • 1. A novel octamer regulatory element in the VH11 leader exon of B-1 cells.
    Goodglick L; Felsher DW; Neshat MS; Braun J
    J Immunol; 1995 May; 154(9):4546-56. PubMed ID: 7722308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of sites for distinct DNA binding proteins including Oct-1 and Oct-2 in the Cr2 gene.
    Christensen SM; Martin BK; Tan SS; Weis JH
    J Immunol; 1992 Jun; 148(11):3610-7. PubMed ID: 1534100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
    Matthias P
    Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A B-cell coactivator of octamer-binding transcription factors.
    Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
    Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The octamer motif present in the Rex-1 promoter binds Oct-1 and Oct-3 expressed by EC cells and ES cells.
    Rosfjord E; Rizzino A
    Biochem Biophys Res Commun; 1994 Sep; 203(3):1795-802. PubMed ID: 7945330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oct-1 transcription factor is a negative regulator of rat CYP1A1 expression via an octamer sequence in its negative regulatory element.
    Sterling K; Bresnick E
    Mol Pharmacol; 1996 Feb; 49(2):329-37. PubMed ID: 8632766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role for Octamer binding protein motifs in the regulation of the proximal preprotachykinin-A promoter.
    Fiskerstrand CE; Newey P; McGregor GP; Gerrard L; Millan F; Quinn JP
    Neuropeptides; 2000 Dec; 34(6):348-54. PubMed ID: 11162291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of human B-cell malignant lymphomas is independent of the octamer lymphoid specific binding factor (Oct-2).
    Kossakowska AE; Urbanski SJ
    Immunology; 1991 Sep; 74(1):37-43. PubMed ID: 1937571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction and functional interference of C/EBPbeta with octamer factors in immunoglobulin gene transcription.
    Hatada EN; Chen-Kiang S; Scheidereit C
    Eur J Immunol; 2000 Jan; 30(1):174-84. PubMed ID: 10602039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spliced oct-1 gene mRNA isoforms with untranslated exons and a deletion in the region coding for the POU-specific domain].
    Deev IE; Zhenilo SV; Polianovskiĭ OL
    Mol Biol (Mosk); 2003; 37(1):139-46. PubMed ID: 12624956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Th2-specific protein/DNA interactions at the proximal nuclear factor-AT site contribute to the functional activity of the human IL-4 promoter.
    Li-Weber M; Salgame P; Hu C; Davydov IV; Laur O; Klevenz S; Krammer PH
    J Immunol; 1998 Aug; 161(3):1380-9. PubMed ID: 9686601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation of the human osteopontin promoter: functional analysis and DNA-protein interactions.
    Wang D; Yamamoto S; Hijiya N; Benveniste EN; Gladson CL
    Oncogene; 2000 Nov; 19(50):5801-9. PubMed ID: 11126367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Proteins, interacting with the promotor of the immunoglobulin kappa gene].
    Kaznadzeĭ DV; Luchina NN; Stepchenko AG; Polianovskiĭ OL
    Mol Biol (Mosk); 1993; 27(5):1023-31. PubMed ID: 8246925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.
    Kistler B; Pfisterer P; Wirth T
    Oncogene; 1995 Sep; 11(6):1095-106. PubMed ID: 7566969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New type of POU domain in germ line-specific protein Oct-4.
    Schöler HR; Ruppert S; Suzuki N; Chowdhury K; Gruss P
    Nature; 1990 Mar; 344(6265):435-9. PubMed ID: 1690859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A lymphoid-specific protein binding to the octamer motif of immunoglobulin genes.
    Staudt LM; Singh H; Sen R; Wirth T; Sharp PA; Baltimore D
    Nature; 1986 Oct 16-22; 323(6089):640-3. PubMed ID: 3095662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential transcription efficiency of two Ig VH promoters in vitro.
    Buchanan KL; Hodgetts SI; Byrnes J; Webb CF
    J Immunol; 1995 Nov; 155(9):4270-7. PubMed ID: 7594585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A melanoma octamer binding protein is responsive to differentiating agents.
    Sturm RA; Bisshop F; Takahashi H; Parsons PG
    Cell Growth Differ; 1991 Oct; 2(10):519-24. PubMed ID: 1751407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of an octamer-like sequence within a crucial region of the androgen-dependent Slp enhancer.
    Scarlett CO; Scheller A; Thompson E; Robins DM
    DNA Cell Biol; 1997 Jan; 16(1):45-57. PubMed ID: 9022044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.